Genentech's Vabysmo Shows Sustained Benefits In Long-Term Studies For Retinal Vein Occlusion
(RTTNews) - Genentech, a member of the Roche Group (RHHBY), said that new long-term data for the company's Vabysmo showed sustained retinal drying...
Stay updated with breaking news from Roche Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(RTTNews) - Genentech, a member of the Roche Group (RHHBY), said that new long-term data for the company's Vabysmo showed sustained retinal drying...
/PRNewswire/ -- Today, the Digital Medicine Society (DiMe) announced it's partnering with Peterson Health Technology Institute (PHTI), ZS Associates, and other...
VectorY Therapeutics, a biotech company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, today announced the appointment of industry veteran Khurem Farooq as independent board member, effective...
This cyclical sector has suffered, post-pandemic, but signs of a recovery are appearing.
/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Roche received European Commission (EC) marketing authorization of...